Fiche centre
Research Site
Besançon — France
Essais liés2clinical trials
VilleBesançonlocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT00695175
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Trastuzumab deruxtecan | Parkinson | Phase 3 | NCT06989112 | DE-01 — DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer | RECRUITING |
| Prophyl C — National Survey on Hypertension in Cardiologic Private Practice | Hypertension | À vérifier | NCT00695175 | Prophyl C — National Survey on Hypertension in Cardiologic Private Practice | COMPLETED |